GREENFIELD, Ind. (Inside INdiana Business) — Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) has announced plans to cut more than 900 jobs globally as part of a restructuring effort following its $7 billion acquisition of Bayer Animal Health.
The company says the affected jobs are primarily in sales and marketing, but also include research and development, manufacturing and quality, and back-office support across 40 countries.
In a news release Wednesday, Elanco said the cuts are being made to reduce duplication, drive efficiency and optimize the company’s footprint around the world.
“The team has rapidly applied our historic integration experience to move with speed and decisiveness and capture initial synergies even during the continued challenges created by the COVID-19 pandemic,” said Jeff Simmons, chief executive officer of Elanco.